Table 2 Input values for standardized analysis in each hypothetical country in the sub-Saharan African (SSA) region, Southeast Asian (SEA) region and Latin America and the Caribbean (LAC) region
Model parameters | Standardized values | ||
|---|---|---|---|
| Â | SSA region | SEA region | LAC region |
Population: | Â | Â | Â |
Total number of birth per year | 60,477 | 932,115 | 140,414 |
Life expectancy at birth (in years) | 59.45 | 70.62 | 72.9 |
Burden of disease: | Â | Â | Â |
Incidence of pneumococcal pneumonia (per 100,000 per year) | 1,793 | 1,793 | 1,771 |
Incidence of meningitis (per 100,000 per year) | 10 | 10 | 18 |
Incidence of invasive NPNM (per 100,000 per year) | 77 | 77 | 137 |
Incidence of otitis media (per 100,000 per year) | 400 | 400 | 400 |
Case fatality rate of pneumococcal pneumonia | 1 | 1 | 1.8 |
Case fatality rate of pneumococcal meningitis | 20 | 20 | 36.8 |
Case fatality rate of invasive NPNM | 10 | 10 | 20.46 |
Vaccine information: | Â | Â | Â |
Vaccine coverage* | 89% | 97% | 83% |
Serotype coverage of pneumococcal pneumonia | 60% | 60% | 60% |
Vaccine efficacy of pneumococcal pneumonia | 97.40% | 97.40% | 97.40% |
Vaccine efficacy of pneumococcal meningitis | 97.40% | 97.40% | 97.40% |
Vaccine efficacy of pneumococcal invasive NPNM | 97.40% | 97.40% | 97.40% |
Vaccine efficacy of otitis media | 57% | 57% | 57% |
Costing information: | Â | Â | Â |
Dose cost | $26.35 | $26.35 | $26.35 |